Insider Shareholders with Direct Ownership of Regulus Therapeutics Inc. (RGLS)
This section provides a comprehensive overview of the insiders with direct ownership of Regulus Therapeutics Inc. (RGLS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Regulus Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Growth Equity Opportunities V, Llc
> 10% Shareholder |
4,398,602 | 0 | 6,451,056 $50.5 Million | 1 |
Dec 04, 2020
Added 40.54%
|
| 3,550,448 | 0 | 1,040,888 $8.15 Million | 5 |
Apr 30, 2025
Added 5.66%
|
|
|
Joseph P Hagan
Chief Executive Officer |
536,600 | 156,058 | 260,808 $2.04 Million | 11 |
Jan 30, 2025
Added 16.09%
|
|
Denis Drygin
Chief Scientific Officer |
100,000 | 0 | 100,000 $783,000 | 2 |
Mar 01, 2022
Added 43.4%
|
| 62,500 | 0 | 90,000 $704,700 | 1 |
Jun 09, 2022
Added 50.0%
|
|
| 66,500 | 0 | 69,240 $542,149 | 2 |
Apr 30, 2025
Added 47.44%
|
|
| 62,500 | 0 | 67,233 $526,434 | 1 |
Apr 30, 2025
Added 48.18%
|
|
| 62,500 | 0 | 64,271 $503,241 | 1 |
Apr 30, 2025
Added 49.3%
|
|
| 62,500 | 0 | 62,500 $489,375 | 1 |
Apr 30, 2025
Added 50.0%
|
|
|
Christopher Ray Aker
Sr. VP & General Counsel |
95,375 | 51,667 | 49,546 $387,945 | 8 |
Jan 14, 2025
Reduced 9.31%
|
|
Crispina Calsada
Chief Financial Officer |
94,750 | 49,272 | 45,478 $356,092 | 5 |
Jan 14, 2025
Reduced 10.06%
|
|
Preston Klassen
President & Head of R & D |
67,500 | 31,445 | 36,055 $282,310 | 2 |
Jan 13, 2025
Reduced 46.59%
|
| 82,110 | 0 | 22,169 $173,583 | 2 |
Jan 30, 2025
Added 46.94%
|